About this Journal Submit a Manuscript Table of Contents
Case Reports in Medicine
Volume 2012 (2012), Article ID 782854, 4 pages
http://dx.doi.org/10.1155/2012/782854
Case Report

Primary Amoebic Meningoencephalitis in an Iranian Infant

1Qom University of Medical Science, Qom, Iran
2Department of Prdiatric Infectious Disease, Qom Children Hospital, Qom University of Medical Science, Imam Boulevard, Qom 37185-3458, Iran

Received 10 April 2012; Revised 20 June 2012; Accepted 20 June 2012

Academic Editor: Arduino A. Mangoni

Copyright © 2012 Zahra Movahedi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. Naegleria fowleri, a free living amoeba, can cause devastating and deadly diseases in humans. This is the first report of primary amoebic meningoencephalitis from Iran. Case report. A five-month-old male infant presented with the history of fever and eye gaze for three days, after beginning of bacterial meningitis, a plain and contrast CT revealed communicated hydrocephalus. In the repeat of CSF analysis on microscopic examination of wet preparation of CSF, Naegleria Fowleri was seen. Then, Amphotericin B and Rifampin were started. On followup, two months later, the patient was totally asymptomatic. Conclusion. Though occurrence of PAM is rare, this unusual disease has grave prognosis, so infection with free living amoebas must be considered in differential diagnosis of pediatric patients of purulent meningitis without evidence of bacteria on Gram’s stain and imaging findings, nonspecific brain edema on CT or hydrocephalus even without history of contact.

1. Introduction

Free living amoebae include many genera with high distribution in natural and artificial environment, such as air, water, dust, and soil. Among the many genera, members of only four genera have an association with human diseases: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri and Sappinia diploidea [1].

Naegleria fowleri, a free living amoeba, can cause devastating and fatal diseases in humans [2]. It causes an acute and fulminating infection of the central nervous system, primary amebic meningoencephalitis (PAM), in healthy children and young adults who indulge in aquatic activities in fresh water. It was first described in 1965 by Fowler and Carter in Australia [3].

About 300 cases of PAM have been reported in the world, mostly in USA, Australia, and Europe. These infections are nearly uniformly fatal with only few survivors of PAM reported [49].

PAM is a fulminant infection that typically leads to death in first or second weeks from the onset of symptoms. The trophozoites, active stages of N. fowleri, infect the brain through the olfactory bulb by penetrating nasal epithelium [10].

Rapid progression of the disease process and limited awareness among the clinicians and diagnostic staff make the disease a diagnostic challenge.

Base of acknowledgment, till date, there have been no reports of PAM due to N. fowleri from Iran.

2. Case Report

A five-month-old male infant presented with the history of fever and eye gaze from 3 days ago. Fever was mild to moderate without any associated chills.

His birth history as well as developmental history was uneventful. The child was immunized up to date. The mother had no signs of mastitis. The child was apparently asymptomatic until two days before admission.

There was no evidence of other focal deficit, altered sensorium, or seizures. Patient neither swam nor recently took a bath in pond, pool, or lake. All relevant history for tuberculosis was negative.

CBC showed WBC 20,500 /mm3 (PMN 65%, lymphocytes 30%, monocytes 1%, eosinophils 1%, band cell 3%), hemoglobin 10.5 g/dL, hematocrit 31.9%, platelet count 731,000 /mm3. Serum electrolyte showed Na = 138, K = 5.7. ESR and CRP were 92 mm/h and 11.3 mg/L, respectively. Stool exam and urine analysis were normal; blood, urine, and stool culture were negative.

A plain and contrast CT revealed communicated hydrocephalus. Following CT, lumbar puncture was done and CSF sent for microbiological and cytological analysis which revealed milky color, 2500 WBC cells/mm3 (PMN = 75%, Lymph = 25%) without any RBC with 391 mg/dL protein and 3 mg/dL of sugar. No bacteria or fungal elements were seen on gram stain. Bacterial culture was negative. Provisional diagnosis of acute bacterial meningitis was made, and the child was treated empirically by intravenous ceftriaxone 100 mg/kg/day and vancomycin 15 mg/kg/dose.

Smear and PCR of CSF for tuberculosis was negative. Four days after starting of vancomycin and ceftriaxone, fever has not decreased so CSF examination was repeated. Second CSF analysis revealed 150 WBC cells/mm3 (PMN = 70%, Lymph = 30%), RBC 500 cells/mm3 with 121 mg/dL protein and 16 mg/dL of sugar. Naegleria Fowleri was seen on microscopic examination of wet preparation of CSF.

Following the demonstration of amoebae in CSF, clinical diagnosis of primary amoebic meningoencephalitis (PAM) was made. Rifampin was started in a dose of 10 mg/kg orally per day and Amphotericin B in a dose of 1 mg/kg/day. CSF culture for Naegleria was also positive.

Three days after beginning of treatment with Amphotericin B and Rifampin, there was improvement in clinical signs and symptoms but fever has not decreased yet, so brain MRI was performed that revealed just hydrocephalus (Figure 1). The patient was referred to the Postgraduate Institute for the insertion of a ventriculoperitoneal shunt. Fever discontinued after surgery. After complete treatment, the patient was discharged. On followup, two months later the patient was totally asymptomatic.

fig1
Figure 1: T1 sagittal (a) and T2 dark fluid transverse (b) view of brain MRI show hydrocephalus.

3. Discussion

Primary amebic meningoencephalitis is divided into PAM and granulomatous amebic encephalitis. PAM is principally caused by N. fowleri in a patient with excellent health with prior intimate contact with fresh water, especially in summer. The portal of entry is via the olfactory mucosa and neuroepithelium. Incubation period is between 3 to 8 days with acute and rapidly fatal course. Patients usually die within 7–10 days of onset of symptoms. The clinical symptoms and signs of this patient were similar to those previously reported but hydrocephalus had not reported before. And this is the first report of PAM with communicating hydrocephalus. Most of the PAM cases are usually misdiagnosed as acute bacterial meningitis or tubercular meningitis [12, 16, 17]. In this case also patient primarily treated based on bacterial meningitis but he did not respond to treatment and in secondary evaluation PAM was diagnosed.

Diagnostic test involves CSF study with direct visualization of Naegleria under light microscope which is actively motile and can be stained with Heidenhain’s iron hematoxylin and Wheatley’s trichrome stain [16]. To date, all pediatric patients with PAM diagnosed by wet smear (Table 1), in this report diagnoses have been done by wet smear, too; but unfortunately we do not have any image of CSF smear and culture.

tab1
Table 1: Pediatric amoebic meningoencephalitis reports.

Biochemical analysis of SCF can also help us to show pleocytosis with neutrophilic dominance and high protein with low sugar. In this case, the color of CSF was milky that has not reported in previous cases and pleocytosis with neutrophil dominance was observed. Indirect hemagglutination, ELISA, and indirect/direct immunofluorescence are other methods used for diagnosis. Although serology is not useful in diagnosis during the acute stage, as antibodies to Naegleria species have also been detected in a normal person [18, 19]. In brain CT of the patient with PAM, hydrocephalus, hemorrhagic edematous confluent foci, can increase intracranial pressure which might have been detected [15]. MRI is usually suggestive of cerebral edema with meningeal enhancement [20]. In this case, MRI revealed hydrocephalus (Figure 1).

Naegleria usually transmitted while swimming or diving in contaminated water and has also been reported from other sources such as tap water and air [21, 22], rare cases have been reported where the infection occurred either by inhalation of air borne cysts or by face washing [23]. Among 7 pediatric reports of PAM, only two patients have had the history of contact.

The drug of choice for treatment of PAM is Amphotericin-B. Rifampin or Tetracycline may be added for better results. All the survivors reported till dates were treated with Amphotericin B.

4. Conclusion

In conclusion, although PAM is rare and has poor prognosis, it should be considered in any patients of pyogenic meningitis without evidence of bacteria by staining, antigen detection and culture. CSF cytology of wet mount becomes mandatory in such cases as early treatment with amphotericin may improve survival.

There should be an increased awareness among the diagnostic staff for careful examination of CSF wet preparation for rapid diagnosis of Naegleria infection as early treatment may markedly improve the prognosis of disease.

References

  1. G. S. Visvesvara, H. Moura, and F. L. Schuster, “Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea,” FEMS Immunology and Medical Microbiology, vol. 50, no. 1, pp. 1–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. G. S. Visvesvara, “Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment,” Current Opinion in Infectious Diseases, vol. 23, no. 6, pp. 590–594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Fowler and R. F. Carter, “Acute pyogenic meningitis probably due to Acanthamoeba sp.: a preliminary report,” British Medical Journal, vol. 2, no. 5464, pp. 740–742, 1965. View at Google Scholar · View at Scopus
  4. F. Loschiavo, T. Ventura-Spagnolo, E. Sessa, and P. Bramanti, “Acute primary meningoencephalitis from entamoeba Naegleria Fowleri. Report of a clinical case with a favourable outcome,” Acta Neurologica, vol. 15, no. 5, pp. 333–340, 1993. View at Google Scholar · View at Scopus
  5. N. Poungvarin and P. Jariya, “The fifth nonlethal case of primary amoebic meningoencephalitis,” Journal of the Medical Association of Thailand, vol. 74, no. 2, pp. 112–115, 1991. View at Google Scholar · View at Scopus
  6. A. Wang, R. Kay, W. S. Poon, and H. K. Ng, “Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong,” Clinical Neurology and Neurosurgery, vol. 95, no. 3, pp. 249–252, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Jain, S. Prabhakar, M. Modi, R. Bhatia, and R. Sehgal, “Naegleria meningitis: a rare survival,” Neurology India, vol. 50, no. 4, pp. 470–472, 2002. View at Google Scholar · View at Scopus
  8. K. Anderson, A. Jamieson, J. B. Jadin, and E. Willaert, “Primary amoebic meningoencephalitis,” The Lancet, vol. 1, no. 7804, p. 672, 1973. View at Google Scholar · View at Scopus
  9. J. Apley, S. K. Clarke, A. P. Roome et al., “Primary amoebic meningoencephalitis in Britain,” British Medical Journal, vol. 1, no. 5696, pp. 596–599, 1970. View at Google Scholar · View at Scopus
  10. J. H. Kim, A. H. Yang, H. J. Sohn, D. Kim, K. J. Song, and H. J. Shin, “Immunodominant antigens in Naegleria fowleri excretory-secretory proteins were potential pathogenic factors,” Parasitology Research, vol. 105, no. 6, pp. 1675–1681, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. N. R. Pan, B. C. Roy, and T. N. Ghosh, “Primary amoebic meningo-encephalitis in two Indian children,” Journal of the Indian Medical Association, vol. 56, no. 5, pp. 134–137, 1971. View at Google Scholar · View at Scopus
  12. S. N. Singh, A. K. Patwari, R. Dutta, N. Taneja, and V. K. Anand, “Naegleria meningitis,” Indian Pediatrics, vol. 35, no. 10, pp. 1012–1015, 1998. View at Google Scholar · View at Scopus
  13. S. Shenoy, G. Wilson, H. V. Prashanth, K. Vidyalakshmi, B. Dhanashree, and R. Bharath, “Primary meningoencephalitis by Naegleria fowleri: first reported case from Mangalore, South india,” Journal of Clinical Microbiology, vol. 40, no. 1, pp. 309–310, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hebbar, I. Bairy, N. Bhaskaranand, S. Upadhyaya, M. S. Sarma, and A. K. Shetty, “Fatal case of Naegleria fowleri meningo-encephalitis in an infant: case report,” Annals of Tropical Paediatrics, vol. 25, no. 3, pp. 223–226, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Vinay, R. Ruchee, H. Shirikiran, V. Shashidhar, M. Sunil, and M. Frenil, “Primary amoebic meningoencephalitis in an infant due to Naegleria fowleri,” Case Reports in Neurological Medicine, vol. 1155, no. 10, pp. 1–3, 2011. View at Google Scholar
  16. A. Wang, R. Kay, W. S. Poon, and H. K. Ng, “Successful treatment of amoebic meningoencephalitis in a Chinese living in Hong Kong,” Clinical Neurology and Neurosurgery, vol. 95, no. 3, pp. 249–252, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. F. Marciano-Cabral and W. A. Petri Jr., “Free living amebae,” in Principles and Practice of Infectious Diseases, G. L. Mandel and J. E. Bannet, Eds., vol. 2, pp. 2408–2414, Churchill Livingstone, New York, NY, USA, 1994. View at Google Scholar
  18. M. F. Reilly, F. Marciano Cabral, D. W. Bradley, and S. G. Bradley, “Agglutination of Naegleria fowleri and Naegleria gruberi by antibodies in human serum,” Journal of Clinical Microbiology, vol. 17, no. 4, pp. 576–581, 1983. View at Google Scholar · View at Scopus
  19. D. T. John, “PAM and the biology of N. Fowleri,” Annual Review of Microbiology, vol. 36, pp. 101–123, 1982. View at Google Scholar
  20. D. D. Kidney and S. H. Kim, “CNS infections with free-living amebas: neuroimaging findings,” American Journal of Roentgenology, vol. 171, no. 3, pp. 809–812, 1998. View at Google Scholar · View at Scopus
  21. N. Gupta, H. Bhaskar, S. Duggal, P. S. Ghalaut, S. Kundra, and D. R. Arora, “Primary amoebic meningoencephalitis: first reported case from Rohtak, North India,” Brazilian Journal of Infectious Diseases, vol. 13, no. 3, pp. 236–237, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. R. V. Lawande, S. N. Abraham, I. John, and L. J. Egler, “Recovery of soil amebas from the nasal passages of children during the dusty harmattan period in Zaria,” American Journal of Clinical Pathology, vol. 71, no. 2, pp. 201–203, 1979. View at Google Scholar · View at Scopus
  23. A. J. Martinez and G. S. Visvesvara, “Free-living, amphizoic and opportunistic amebas,” Brain Pathology, vol. 7, no. 1, pp. 583–598, 1997. View at Google Scholar · View at Scopus